Carbapenemase-Encoding Genes in Carbapenem-Resistant Enterobacter cloacae: Transmission Dynamics and Resistance in Guangdong Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) represents an escalating threat in clinical microbiology, particularly within tertiary hospital settings. The surge in antibiotic usage and healthcare disruptions during the COVID-19 pandemic has compounded the spread of multidrug-resistant organisms. Although carbapenemase-encoding genes (CEGs) are recognized as principal drivers of resistance in Enterobacteriaceae, the detailed molecular epidemiology and transmission mechanisms of these genes in CREC—especially amidst pandemic conditions—remain incompletely understood. The reference study sought to fill this critical gap by systematically analyzing CEG prevalence, localization, transfer dynamics, and epidemiological correlates among CREC isolates from eight teaching hospitals in Guangdong Province, China, collected between December 2022 and June 2024.

Key Innovation from the Reference Study

The standout innovation of this investigation lies in its integrated molecular and epidemiological approach to dissecting the carriage and transmissibility of CEGs in CREC. Leveraging both plasmid-curing and PCR-based genotyping, the researchers established not only the high prevalence of CEGs, but also clarified their chromosomal versus plasmid localization and the efficiency of horizontal gene transfer under clinically relevant conditions. This dual focus delivers actionable insights into how resistance determinants proliferate within and between hospital departments, directly informing antimicrobial surveillance and infection control strategies.

Methods and Experimental Design Insights

The study analyzed 54 non-duplicated CREC isolates. Key methodologies included:

• Plasmid elimination: Variable temperature sodium dodecyl sulfate (SDS) treatment enabled determination of CEG plasmid versus chromosomal localization.
• PCR amplification: Targeted detection of bla_NDM−1, bla_IMP, and bla_KPC−2 genes.
• Broth microdilution: Quantitative antimicrobial susceptibility testing for several clinically relevant antibiotics.
• Plasmid conjugation assays: Assessment of CEG transferability between strains.
• Molecular typing: ERIC-PCR and NTSYS clustering to define genotype diversity and distribution across clinical departments.
• Mobile genetic element profiling: Identification of insertion sequences (e.g., ISEcp1) associated with gene mobility.

This multifaceted design allowed the authors to link gene presence and mobility with phenotypic resistance and epidemiological patterns.

Protocol Parameters

• Plasmid curing by SDS: Variable temperature incubation with 10% SDS; duration and temperature gradients optimized for Enterobacteriaceae, as described in the study.
• PCR detection: Specific primer sets for bla_NDM−1, bla_IMP, and bla_KPC−2; cycling conditions tailored for high specificity.
• Conjugation frequency assessment: Mating experiments performed in broth culture at 37°C for 24 hours, with selection on antibiotic-containing media.
• Antibiotic susceptibility: Broth microdilution panels included imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Genotyping: ERIC-PCR banding patterns analyzed using NTSYS software for cluster assignment.

Core Findings and Why They Matter

The reference study revealed several critical results:

• CEG Prevalence: 85.19% (46/54) of CREC isolates harbored at least one carbapenemase-encoding gene.
• Gene Distribution: The bla_NDM−1 gene was the most prevalent, detected on both chromosomes and plasmids in 33.33% of isolates, and exclusively on plasmids in 46.30%. Other detected genes included bla_IMP (3.70%, plasmid-only) and a rare co-carriage of bla_NDM−1 and bla_KPC−2 (1.85%, plasmid-only).
• Antibiotic Resistance: CEG-positive strains exhibited significantly higher resistance to multiple antibiotic classes, including carbapenems and fluoroquinolones.
• Horizontal Transfer: Plasmid conjugation experiments demonstrated a 95.65% success rate for CEG transfer, with particularly high rates for bla_NDM−1 and bla_IMP. This underscores the potential for rapid dissemination of resistance determinants within healthcare environments.
• Mobile Genetic Elements: Six types of insertion sequences were identified, with ISEcp1 being the most common (87.04%). The frequent co-occurrence of multiple mobile elements in single strains (up to four types) suggests a high mobility landscape for resistance genes.
• Genotypic Diversity: ERIC-PCR typing grouped isolates into 17 genotypes, with some clusters (type E and G) distributed across multiple hospitals and departments, indicating inter-ward and inter-hospital dissemination.
• Epidemiological Correlates: Higher CEG detection rates were observed among male and elderly patients, in respiratory medicine, and in sputum samples.

Collectively, these findings highlight the role of plasmid-mediated gene transfer and mobile genetic elements in the rapid propagation of multidrug resistance among CREC populations in clinical settings. The predominance of bla_NDM−1—especially when plasmid-encoded—raises urgent concerns for infection control and therapeutic options.

Comparison with Existing Internal Articles

Several internal resources offer additional context on the molecular tools and protocols underpinning resistance gene studies:

• The article Chloramphenicol: Mechanistic Benchmarks in Molecular Biology reviews the use of chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide) as a bacterial protein synthesis inhibitor in plasmid selection assays and resistance research, underscoring its role in validating plasmid-borne gene function.
• Chloramphenicol in Plasmid Selection: Protocols & Innovations details high-stringency selection workflows relevant for studying horizontal gene transfer and plasmid stability, directly paralleling the reference study’s conjugation and selection experiments.
• Mechanistic discussions in Chloramphenicol in Modern Molecular Biology: Mechanisms further contextualize the antibiotic’s specificity for the bacterial 50S ribosomal subunit, a principle mirrored in the selection of resistance markers for clinical and laboratory research.

These resources collectively reinforce the methodological rigor required for dissecting antibiotic resistance mechanisms and support the importance of precise molecular tools such as chloramphenicol for plasmid selection and validation.

Limitations and Transferability

While the study offers robust molecular and epidemiological insights, several limitations warrant consideration. The sample size, though diverse, remains geographically confined to eight hospitals in Guangdong, potentially limiting generalizability beyond the region. Furthermore, while plasmid localization and conjugation dynamics were carefully mapped, the study did not extensively characterize the full plasmidome or explore resistance determinants outside the target CEGs. Environmental and community reservoirs were also not addressed. Nevertheless, the methods and findings are highly transferable to similar hospital-based surveillance and molecular epidemiology efforts worldwide, particularly where multidrug-resistant Enterobacteriaceae are prevalent.

Research Support Resources

For molecular biology researchers aiming to replicate or extend plasmid selection assays, the use of high-purity chloramphenicol (SKU A2512) is well supported by both internal resources and the reference study’s workflow. Chloramphenicol’s established role as a potent inhibitor of bacterial protein synthesis, and its utility in stringent plasmid selection, make it a valuable reagent for studies involving the identification and transfer of antibiotic resistance genes. Detailed protocols and troubleshooting guides are available in internal articles, notably Chloramphenicol: Mechanistic Benchmarks in Molecular Biology. Researchers should ensure optimal handling and storage conditions for maximum reagent integrity, as outlined in the product specification. Chloramphenicol is intended for research use only and should not be employed for diagnostic or medical purposes.